Method for evaluating multiple types of cardiotoxicity of tumor patients
A technology for patients with cardiotoxicity and tumors, applied in pathological reference, health index calculation, medical simulation, etc., can solve problems such as limited evaluation factors, increased risk of cardiotoxicity, and negative effects on the heart
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0098] A 75-year-old female breast cancer patient has completed four cycles of AC-T regimen treatment and is in the stage of single-drug docetaxel chemotherapy. According to its clinical data, the risk factors and scores related to cardiotoxicity can be listed, and the total score and risk degree can be calculated. details as follows:
[0099] 1. Cardiac insufficiency
[0100]
[0101] 2. Coronary artery disease
[0102]
[0103] 3. Hypertension
[0104]
[0105] 4. Arrhythmia
[0106]
[0107] 5. Stroke and Thrombosis
[0108]
[0109] 6. Prolonged QT interval
[0110]
[0111] To sum up, because the patients in Example 1 have a high-risk rating, the overall rating is determined as a high-risk rating. According to its overall rating, the recommendations corresponding to the high-risk rating are given as follows: transthoracic echocardiography with strain before chemotherapy, every 3 cycles of chemotherapy, at the end, 3-6 months after the end, and 1 ye...
Embodiment 2
[0113] A 57-year-old male patient with colon cancer, more than 3 years after surgery for colon cancer, found extensive abdominal metastases for 2 years, and was admitted to the hospital for treatment. According to its clinical data, the risk factors and scores related to cardiotoxicity can be listed, and the total score and risk degree can be calculated. details as follows:
[0114] 1. Cardiac insufficiency
[0115]
[0116] 2. Coronary artery disease
[0117]
[0118] 3. Hypertension
[0119]
[0120] 4. Arrhythmia
[0121]
[0122] 5. Stroke and Thrombosis
[0123]
[0124] 6. Prolonged QT interval
[0125]
[0126] To sum up, because the patient in Example 2 has a high-risk rating, the overall rating is determined as a high-risk rating. According to its overall rating, the recommendations corresponding to the high-risk rating are given as follows: transthoracic echocardiography with strain before chemotherapy, every 3 cycles of chemotherapy, at the e...
Embodiment 3
[0128] The present invention fully excavates and analyzes the medical data of cancer patients, and trains an analysis model. In this embodiment, the analysis model is used to evaluate the cardiotoxicity of cancer patients, so as to prevent and reduce the cardiac damage caused by cancer treatment. toxicity. The analysis model can be updated regularly with the accumulation of medical data of cancer patients, making the evaluation results more and more accurate. It can also evaluate and predict the cardiotoxicity of patients diagnosed with cancer, so as to assist medical staff in minimizing cardiotoxicity. Under the premise of formulating the optimal treatment plan.
[0129] Such as Figure 9 It is a method for establishing a cardiotoxicity assessment model for cancer patients and a calibration and optimization method provided in the embodiment of the present application, and the method includes the following steps.
[0130] S1. Obtain baseline data and cardiotoxicity results o...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com